Supermax Corporation

Equities

SUPERMX

MYL7106OO007

Medical Equipment, Supplies & Distribution

End-of-day quote BURSA MALAYSIA 06:00:00 2024-07-18 pm EDT 5-day change 1st Jan Change
0.92 MYR -1.08% Intraday chart for Supermax Corporation +1.10% -2.13%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
Supermax Repurchases Shares MT
Supermax Repurchases Shares MT
Supermax Buys Back 1 Million Shares MT
Supermax Corporation Berhad Announces No Dividend in the Current Quarter and Financial Year-To-Date Ended 31 March 2024 CI
Supermax Trims Loss in Fiscal Q3 MT
Supermax Corporation Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Supermax Buys Back 1 Million Shares MT
Supermax Buys Out Supermax Healthcare Canada for C$5.5 Million MT
Supermax Corporation Berhad entered into a Share Sale Agreement to acquire remaining 33% stake in Supermax Healthcare Canada Inc. from Sylvain Bergeron for CAD 5.5 million. CI
Supermax Corporation Berhad Announces Resignation of Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee CI
Supermax Corporation Berhad Announces Resignation of Dr. Yap Lang Ling as Independent and Non Executive Director CI
Supermax Buys Back Shares MT
Supermax Corporation Berhad Announces Audit Committee Changes, Effective May 8, 2024 CI
Supermax Corporation Berhad Announces Re-Designation of Wong Phait Lee from Non Executive Director to Executive Director, Effective May 8, 2024 CI
Supermax Buys Back Shares MT
Supermax Buys Back Shares MT
Supermax Corporation Berhad commences an Equity Buyback Plan, under the authorization approved on December 8, 2023. CI
Supermax Corporation Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI
Supermax Names CEO, COO MT
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024 CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024 CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok, as Independent and Non Executive Member of Risk Committee, Effective 02 Jan 2024 CI
Supermax Corporation Berhad Appoints Yip Kit Weng as Independent and Non Executive Director, Effective January 2, 2024 CI
Supermax Corporation Berhad Announces Resignation of Albert Saychuan Cheok as Independent and Non Executive Member of Risk Committee, Effective January 2, 2024 CI
Supermax Corporation Berhad Appoints Yap Lang Ling as Independent and Non Executive Chairman of Risk Committee, Effective January 2, 2024 CI
Chart Supermax Corporation
More charts
Supermax Corporation Berhad is an investment holding company, engaged in the production of rubber gloves. It is an international manufacturer, distributor and marketer of medical devices, namely medical gloves and contact lenses. It operates through four segments: Investment holding, Manufacturing of gloves, Trading of gloves and Others. It manufactures various types of nitrile latex and natural rubber gloves, which are exported to over 165 countries around the world, such as the United States of America, European Union, Middle East, Asia, and South Pacific countries. The Company owns a range of brands, such as Supermax, Aurelia and Maxter, which are used by laboratories, hospitals, pharmacists, doctors, and surgeons throughout the world. It distributes its gloves through distribution centers set up around the world as well as in collaboration with a wide network of over 1,200 distributors globally. Its subsidiaries include Supermax Property Holdings Sdn Bhd and Supergamma Sdn. Bhd.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
0.92 MYR
Average target price
0.9583 MYR
Spread / Average Target
+4.17%
Consensus

Annual profits - Rate of surprise